1. HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies

   • Saima Subhani
   • Divya Teja Vavilala
   • Mridul Mukherji

   Review Paper 04 May 2016 Pages: 257 - 273

   

2. ETS transcription factors in embryonic vascular development

   • Michael P. Craig
   • Saulius Sumanas

   Review Paper 28 April 2016 Pages: 275 - 285

   

3. Plants and their active compounds: natural molecules to target angiogenesis

   • Kai Lu
   • Madhavi Bhat
   • Sujit Basu

   Review Paper 06 May 2016 Pages: 287 - 295

   

4. EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease

   • Du Yang
   • Chunna Jin
   • Meixiang Xiang

   Review Paper 23 May 2016 Pages: 297 - 309

   

5. Quercitrin treatment protects endothelial progenitor cells from oxidative damage via inducing autophagy through extracellular signal-regulated kinase

   • Kangkang Zhi
   • Maoquan Li
   • Lefeng Qu

   Original Paper 26 March 2016 Pages: 311 - 324

   

6. CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs)

   • Dimitar Tasev
   • Lara S. F. Konijnenberg
   • Victor W. M. van Hinsbergh

   Original Paper Open access 04 April 2016 Pages: 325 - 338

   

7. VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue

   • Ernesta Fagiani
   • Pascal Lorentz
   • Gerhard Christofori

   Original Paper 01 April 2016 Pages: 339 - 358

   

8. mTORC2 mediates CXCL12-induced angiogenesis

   • Mary E. Ziegler
   • Michaela M. S. Hatch
   • Christopher C. W. Hughes

   Original Paper 22 April 2016 Pages: 359 - 371

   

9. Pigment epithelium-derived factor (PEDF): a novel trophoblast-derived factor limiting feto-placental angiogenesis in late pregnancy

   • Jelena Loegl
   • Erika Nussbaumer
   • Berthold Huppertz

   Original Paper Open access 08 June 2016 Pages: 373 - 388

   

10. Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

    • Douglas A. MacDonald
    • Joel Martin
    • Nicholas Papadopoulos

    Original Paper Open access 27 May 2016 Pages: 389 - 406

    

11. Association of endothelial proliferation with the magnitude of weight loss during calorie restriction

    • Katarzyna Korybalska
    • Ewelina Swora-Cwynar
    • Janusz Witowski

    Original Paper 31 May 2016 Pages: 407 - 419

    

12. Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness

    • Mohamed Abo El-Asrar
    • Nancy Samir Elbarbary
    • AlShaimaa Abo Bakr

    Original Paper 28 May 2016 Pages: 421 - 431

    

13. Vegfr3-CreER ^T2 mouse, a new genetic tool for targeting the lymphatic system

    • Ines Martinez-Corral
    • Lukas Stanczuk
    • Sagrario Ortega

    Brief Communication 18 March 2016 Pages: 433 - 445

    

14. Erratum to: Vegfr3-CreER ^T2 mouse, a new genetic tool for targeting the lymphatic system

    • Ines Martinez-Corral
    • Lukas Stanczuk
    • Sagrario Ortega

    Erratum 06 June 2016 Pages: 447 - 447

15. Erratum to: In situ validation of VEGFR-2 and α _v ß ₃ integrin as targets for breast lesion characterization

    • Josef Ehling
    • Matthias Misiewicz
    • Fabian Kiessling

    Erratum 30 March 2016 Pages: 449 - 449